Overall, the available evidence suggests that GLP-1 RA use is not associated with an increased risk of depression in adults with type 2 diabetes, though heterogeneity across studies highlights the need for further prospective research with standardized psychiatric outcome assessment. The gene discussed is GCG; the disease is type 2 diabetes mellitus.